Vitalab Methylcobalamin Injection Recalled Due to Sterility Concerns
Vitalab Pharmacy is recalling 178 vials of Methylcobalamin for injection because airflow patterns may not support aseptic production, raising sterility concerns.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls with potential for adverse health consequences (such as sterility issues in injectables) are categorized as Severe.
Plain-English summary
Vitalab Pharmacy, Inc. is recalling 178 vials of Methylcobalamin for injection, 1mg/mL and 10 mg/mL, sterile injectable. The recall is due to a lack of assurance of sterility. Upon review of recent third-party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.
The recalled product was distributed to patients throughout the United States. The affected lots include 02122018@77, 03092018@52, 02122018@76, 03142018@32, 01312018@40, 12282017@31, 01232018@17, 03052018@54, 03082018@39, 02082018@55, 02082018@56, 03062018@69, 02052018@56, 03122018@62, 02072018@95, 03122018@63, 02072018@96, 03122018@64, and 02072018@97. The expiration dates for these products range from 05/06/2018 to 09/10/2018.
Patients who have received these products should contact their healthcare provider for guidance. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Methylcobalamin for injection, 1mg/mL and 10 mg/mL, Sterile injectable, Vitalab Pharmacy, Inc
- Manufacturer
- Vitalab Pharmacy, Inc
- Category
- Drug — Injectable
- Hazard
- Affected units
- 178
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Lot #: 02122018@77
- 03092018@52
- 02122018@76
- 03142018@32
- 01312018@40
- 12282017@31
- 01232018@17
- 03052018@54
- 03082018@39 02082018@55
- 02082018@56
- 03062018@69
- 02052018@56
- 03122018@62 02072018@95
- 03122018@63
- 02072018@96
- 03122018@64
- 02072018@97
- Exp 05/06/2018-09/10/2018
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 6 recalled by Vitalab Pharmacy, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Vitalab Pharmacy, Inc
See all →- SevereVitalab Pharmacy Recalls Sterile Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- HighVitalab Pharmacy Recalls Sterile Injectable Drugs Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- SevereVitalab Pharmacy Recalls Sterile Injectable Drugs Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- SevereVitalab Pharmacy Recalls Sterile Injectable Drug Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- SevereVitalab Alprostadil Injectable Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2018-05-16
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29